You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Octreotide

Showing 1 - 25 of 391
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)

Completed
  • Pancreatic Neuroendocrine Tumor G2
  • Octreotide LAR
  • (no location specified)
Oct 17, 2023

Non-variceal Gastrointestinal Bleeding Trial in Cairo (PPI group, PPI plus octreotide)

Recruiting
  • Non-variceal Gastrointestinal Bleeding
  • PPI group
  • PPI plus octreotide
  • Cairo, Egypt
    NHTMRI
Sep 28, 2023

Hepatic Carcinoma, Hepatic Metastasis Trial in Pamplona (Octreotide, Placebo)

Recruiting
  • Hepatic Carcinoma
  • Hepatic Metastasis
  • Octreotide
  • Placebo
  • Pamplona, Spain
    Clinica Universidad de Navarra
Oct 10, 2023

Lymphatic Diseases, Chylothorax Trial in København Ø (Octreotide Injection, Saline infusion)

Completed
  • Lymphatic Diseases
  • Chylothorax
  • Octreotide Injection
  • Saline infusion
  • København Ø, Denmark
    Rigshospitalet
Jan 4, 2023

Seroma Following Procedure Trial in Ibadan (Octreotide Injection, Sterile water)

Completed
  • Seroma Following Procedure
  • Octreotide Injection
  • Sterile water
  • Ibadan, Oyo, Nigeria
    University College Hospital
Jan 13, 2023

Neuroendocrine Tumor Trial in Beijing (Al18F-octreotide)

Recruiting
  • Neuroendocrine Tumor
  • Beijing, Chao Yang, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023

Acromegaly Trial in Beijing (SYHX2008 injection, Octreotide Acetate Microspheres for Injection injection, Sandostatin ®

Recruiting
  • Acromegaly
  • SYHX2008 injection
  • +3 more
  • Beijing, Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Mar 13, 2023

Advanced Gastroenteropancreatic Neuroendocrine Tumor Trial (Lutetium (177Lu) Oxodotreotide Injection;long-acting Octreotide,

Not yet recruiting
  • Advanced Gastroenteropancreatic Neuroendocrine Tumor
  • Lutetium (177Lu) Oxodotreotide Injection；long-acting Octreotide
  • long-acting Octreotide.
  • (no location specified)
May 22, 2023

Esophageal Cancer, Gastric Cancer Trial in Stockholm (Octreotide Injection)

Recruiting
  • Esophageal Cancer
  • Gastric Cancer
  • Octreotide Injection
  • Stockholm, Sweden
    Karolinska University Hospital, Huddinge
Aug 16, 2022

Healthy Trial in Durham (Octreotide 1 MG/ML)

Completed
  • Healthy
  • Octreotide 1 MG/ML
  • Durham, North Carolina
    Duke University Medical Center
Apr 15, 2022

Polycystic Liver Disease Trial in Rochester, Dallas (CAM2029, Placebo)

Recruiting
  • Polycystic Liver Disease
  • Rochester, Minnesota
  • +6 more
Jan 18, 2023

Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • 90Y-DOTA tyr3-Octreotide
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Oct 6, 2022

Neuroendocrine Tumors Trial in Leuven (Al18F-NOTA-octreotide, PET/CT, PET/MR)

Completed
  • Neuroendocrine Tumors
  • Leuven, Belgium
    Universitaire Ziekenhuizen Leuven
Feb 16, 2022

Octreotide in the Treatment of Congenital Hyperinsulinemia

Completed
  • Congenital Hyperinsulinaemic Hypoglycaemia
  • Octreotide Adverse Reaction
  • Octreotide Injection
  • Beijing, Beijing, China
    Department of Endocrinology, Genetics, Metabolism
Dec 19, 2021

Autosomal Dominant Polycystic Kidney Disease Trial in Ranica (Tolvaptan, Octreotide LAR, Placebo)

Completed
  • Autosomal Dominant Polycystic Kidney Disease
  • Ranica, Bergamo, Italy
    CRC per le Malattie Rare Aldo e Cele Daccò
Mar 10, 2022

Malignant Bowel Obstruction Trial in Buffalo (Dexamethasone, Metoclopramide, Octreotide)

Terminated
Has Results
  • Malignant Bowel Obstruction
  • Buffalo, New York
    Roswell Park Cancer Institute
Nov 9, 2022

Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • (no location specified)
Sep 13, 2023

Haemorrhagic Shock, Variceal Hemorrhage Trial in Amiens (Octreotide Injection)

Recruiting
  • Haemorrhagic Shock
  • Variceal Hemorrhage
  • Octreotide Injection
  • Amiens, France
    CHU Amiens Picardie
Nov 8, 2021

Neuroendocrine Tumors Trial in United States (Octreotide, LAR Lanreotide, Questionnaires)

Active, not recruiting
  • Neuroendocrine Tumors
  • Octreotide
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Apr 20, 2022

Roux-en-Y Bariatric Surgery Trial in Dublin (Octreotide, Saline)

Completed
  • Roux-en-Y Bariatric Surgery
  • Dublin, Ireland
    University College Dublin Clinical Research Centre
May 20, 2022

Insulin Resistance, Prediabetic State, Non-Alcoholic Fatty Liver Disease Trial in New York (drug, other, dietary supplement,

Not yet recruiting
  • Insulin Resistance
  • +3 more
  • Insulin human
  • +11 more
  • New York, New York
    Columbia University Irving Medical Center
Nov 6, 2023

Neuroendocrine Tumors Trial in China (Lutetium[177Lu] Oxodotreotide Injection, Octreotide LAR)

Not yet recruiting
  • Neuroendocrine Tumors
  • Lutetium[177Lu] Oxodotreotide Injection
  • Octreotide LAR
  • Beijing, Beijing, China
  • +20 more
Jul 25, 2022

Breast Cancer, Lymphocele Trial (Injection of sandostatine)

Terminated
  • Breast Cancer
  • Lymphocele
  • Injection of sandostatine
  • (no location specified)
Jul 26, 2022

Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)

Terminated
Has Results
  • Acromegaly
  • Los Angeles, California
    Cedars-Sinai Medical Center
Dec 12, 2022

Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)

Active, not recruiting
  • Well Differentiated Pancreatic Endocrine Tumor
  • Everolimus plus Octreotide LAR plus Metformin
  • Milano, Italy
    Fondazione IRCCS Istituto Tumori Milano
Sep 3, 2021